Prelude Capital Management’s National Healthcare NHC Stock Holding History

Prelude Capital Management’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-260	Closed	-$19K	–	2166
2020 Q1	$19K	Sell	260 -190	-42%	-$15K	﹤0.01%	1000
2019 Q4	$39K	Buy	+450	New	+$37.6K	﹤0.01%	1426
2018 Q3	–	Sell	-492	Closed	-$35K	–	1938
2018 Q2	$35K	Sell	492 -2,500	-84%	-$164K	﹤0.01%	1227
2018 Q1	$178K	Buy	2,992 +1,592	+114%	+$97.6K	0.01%	707
2017 Q4	$85K	Hold	1,400	–	–	0.01%	825
2017 Q3	$88K	Buy	1,400 +800	+133%	+$51.5K	0.01%	923
2017 Q2	$42K	Hold	600	–	–	﹤0.01%	1057
2017 Q1	$43K	Hold	600	–	–	﹤0.01%	1060
2016 Q4	$45K	Sell	600 -700	-54%	-$48.5K	0.01%	1073
2016 Q3	$86K	Hold	1,300	–	–	0.01%	874
2016 Q2	$84K	Buy	1,300 +500	+63%	+$31.7K	0.01%	822
2016 Q1	$50K	Buy	800 +500	+167%	+$31.1K	0.01%	974
2015 Q4	$19K	Sell	300 -100	-25%	-$6.48K	﹤0.01%	1199
2015 Q3	$24K	Buy	400 +100	+33%	+$6.26K	﹤0.01%	1221
2015 Q2	$19K	Buy	+300	New	+$19K	﹤0.01%	1391
2014 Q3	–	Sell	-700	Closed	-$39K	–	2035
2014 Q2	$39K	Hold	700	–	–	0.01%	1486
2014 Q1	$39K	Hold	700	–	–	0.01%	1393
2013 Q4	$38K	Buy	+700	New	+$35.8K	0.01%	1129

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Prelude Capital Management's NHC Position: Q2 2020 in Review

Prelude Capital Management sold out of National Healthcare (NHC) in Q2 2020, closing a stake of 260 shares — an estimated $19K sold.

Prelude Capital Management first reported a position in NHC in Q4 2013 and held it in 18 quarters. The position peaked at $178K in Q1 2018. 138 funds tracked by Wall St. Rank hold NHC as of Q2 2020.

Prelude Capital Management reported no remaining National Healthcare position as of Q2 2020 after selling out during the quarter.
Prelude Capital Management sold 260 National Healthcare shares in Q2 2020, an estimated $19K.
Prelude Capital Management first reported a position in National Healthcare in Q4 2013 and held it in 18 quarters.
Prelude Capital Management's National Healthcare position peaked at $178K in Q1 2018.
138 funds tracked by Wall St. Rank held National Healthcare as of Q2 2020.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.